Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5731 AL 5745

Reply: "Unilateral Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Pallidothalamic Tractotomy in Parkinson's Disease: Promising Results But Uncertain Target"

Ikezawa J, Yokochi F, Yamaguchi T, Abe K, Kamiyama T, Kawazoe T, Horisawa S, Sasanuma J, Hori T, Hori H, Kakegawa T, Okiyama R, Takahashi K, Taira T.

Mov Disord. 2026 Jan;41(1):271-272. doi: 10.1002/mds.70130. Epub 2025 Nov 18.

Resting-state EEG changes associated with cognitive decline in Parkinson's disease: a systematic review

Spoa M, Monti S, Bjekić J, Guerra A, Fiorenzato E, Cauzzo S, Bertoldo A, Antonini A.

J Neural Transm (Vienna). 2026 Apr;133(4):731-765. doi: 10.1007/s00702-025-03065-0. Epub 2025 Nov 18.

Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer's and Parkinson's disease

Siu ACW, Paudel KR, Singh G, Gupta G, Singh SK, Chellappan DK, De Rubis G, Pathak S, Gregory George Oliver B, Dua K, Dhanasekaran M.

Mol Cell Biochem. 2026 Feb;481(2):669-694. doi: 10.1007/s11010-025-05428-3. Epub 2025 Nov 18.

Daily steps and health outcomes: Implications for persons with Parkinson's disease

Oosterhof TH, Bloem BR, de Vries NM, Darweesh SK, Schootemeijer S.

J Parkinsons Dis. 2026 Feb;16(1):196-197. doi: 10.1177/1877718X251397278. Epub 2025 Nov 18.

Corrigendum to "Dissolvable microarray patches of levodopa and carbidopa for Parkinson's disease management" [Eur. J. Pharm. Biopharm. 199 (2024) 114304]

Anjani QK, Moreno-Castellanos N, Li Y, Sabri AHB, Donnelly RF.

Eur J Pharm Biopharm. 2026 Jan;218:114928. doi: 10.1016/j.ejpb.2025.114928. Epub 2025 Nov 17.

Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Extended Real World Data with Outpatient Dose Titration

Bradley M, Coran M, Donlon E, Gallagher A, Ruggieri F, Inocentes J, Diaz Rua A, O'Keeffe C, Lynch T, Walsh RA, Fearon C.

Mov Disord Clin Pract. 2026 Apr;13(4):1108-1110. doi: 10.1002/mdc3.70397. Epub 2025 Nov 19.

REPLY: Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Extended Real World Data With Outpatient Dose Titration

Rukavina K, Ebersbach G, Gruber D.

Mov Disord Clin Pract. 2026 Apr;13(4):1111-1112. doi: 10.1002/mdc3.70396. Epub 2025 Nov 19.

Efficacy of Mediterranean diet for the prevention of neurological diseases: A systematic review and meta-analysis featured in the Italian National Guidelines "La Dieta Mediterranea"

Zuliani G, Gianfredi V, Veronese N, Volpe M, Maggi S, Onder G, Silano M, Nucci D, Zanetti M, Benussi A, Burgio MI, Fadda M, Guindani P, Sollai S, Cereda E, Caffarra P.

Nutrition. 2026 Feb;142:112990. doi: 10.1016/j.nut.2025.112990. Epub 2025 Oct 11.

Celastrol as a neuroprotective drug: current status and challenges

Wang X, Li W, Liu X, Liang J, Wang L, Liu G, Liu Y, Song M, Li Z, Guo Y, Li S, Fu N, Zhang B.

Int Immunopharmacol. 2026 Jan 1;168(Pt 2):115846. doi: 10.1016/j.intimp.2025.115846. Epub 2025 Nov 19.

Effects of Deep Brain Stimulation on Autonomic Symptoms in Parkinson's Disease: A Scoping Review

Chen J, Silva J, Goyal A, Ayer D, McCarthy P, Opiela A, Harland T.

Mov Disord Clin Pract. 2026 Apr;13(4):862-875. doi: 10.1002/mdc3.70429. Epub 2025 Nov 20.

Similar DTI-ALPS metrics in Parkinson's disease and essential tremor: a cross-sectional comparative analysis

Bruno F, Innocenzi A, Badini P, Cella M, Santobuono C, Pertici L, Catalucci A, Saporito G, Sucapane P, Palumbo P, Arrigoni F, Barile A, Di Cesare E, Pistoia F, Splendiani A.

Neuroradiology. 2026 Feb;68(2):483-491. doi: 10.1007/s00234-025-03840-6. Epub 2025 Nov 20.

Vestibular-evoked myogenic potentials and dizziness profiles in Parkinson's disease: Commentary on a controlled study

Erdem M.

Clin Neurol Neurosurg. 2026 Jan;260:109260. doi: 10.1016/j.clineuro.2025.109260. Epub 2025 Nov 19.

A mechanistic insight of neuro-inflammation signaling pathways and implication in neurodegenerative disorders

Shafi A, Akmal M, Sethi A, Chauhdary Z.

Inflammopharmacology. 2026 Jan;34(1):309-318. doi: 10.1007/s10787-025-02041-0. Epub 2025 Nov 21.

Frailty across Neurological Diseases: Why Sex and Gender Matter

Lorefice L, Pellecchia MT.

Ann Neurol. 2026 Feb;99(2):297-311. doi: 10.1002/ana.78110. Epub 2025 Nov 21.

Titration Dynamics and Early Treatment Burden in Advanced Parkinson's Disease: A Multicenter Comparison of CSFLI and LCIG Infusion Therapies

Pinna B, Fenu G, Mellino P, Serra G, Cadeddu G, Murgia D, Gozzi A, Antenucci P, Tessitore A, Ciaramaglia O, Modugno N, Pietracupa S, Avenali M, Zangaglia R, Valentino F, Pisani A, Mascia MM, Puligheddu M, Zibetti M, Imbalzano G, Lopiano L, Calandra-Buonaura G, Giannini G, Baldelli L, Cani I, Solla P, Ercoli T, Sensi M, De Micco R, Morgante F, Cossu G.

Mov Disord Clin Pract. 2026 May;13(5):1277-1282. doi: 10.1002/mdc3.70448. Epub 2025 Nov 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias